Insights From the SNMMI Theranostics Conference

Ana Kiess, MD, PhD, Johns Hopkins Medicine

Videos

Personalizing Theranostics: Adaptive Dosing Strategies Informed by Radiation Oncology

02/12/2026

Ana Kiess, MD, PhD

Ana Kiess, MD, PhD, Johns Hopkins Medicine, Baltimore, Maryland, discusses how lessons from external beam radiation therapy can guide adaptive dosing strategies in theranostics to improve tumor control while balancing toxicity.

Ana Kiess, MD, PhD, Johns...

02/12/2026

Radiopharmaceutical Education Institute

Praful Ravi, MB, BChir, MRCP, Dana-Farber Cancer Institute

Videos

PSMA Radioligand Therapy in Hormone-Sensitive Prostate Cancer: Lessons from the PSMAddition Trial

02/12/2026

Praful Ravi, MB, BChir, MRCP

Praful Ravi, MB, BChir, MRCP, discusses the potential role of PSMA radioligand therapy in metastatic hormone-sensitive prostate cancer, highlighting radiographic PFS benefits from the PSMAddition trial while emphasizing the need to balance...

Praful Ravi, MB, BChir, MRCP,...

02/12/2026

Radiopharmaceutical Education Institute

Videos

2025 ATA Guideline Updates for Differentiated Thyroid Cancer: What Oncologists Need to Know

02/12/2026

Robert Flavell, MD, PhD

Robert Flavell, MD, PhD, reviews the 2025 ATA guidelines for differentiated thyroid cancer, highlighting updated risk stratification, refined recommendations for radioactive iodine use, expanded use of SPECT/CT imaging, and new guidance on...

Robert Flavell, MD, PhD, reviews...

02/12/2026

Radiopharmaceutical Education Institute

Insights From the SNMMI Theranostics Conference

HMP Global Products

Events